About PeriGen
PeriGen is a company based in Cranbury (United States) founded in 1995 was acquired by Halma in April 2021. PeriGen has raised $11 million across 3 funding rounds from investors including Halma, Ambina Partners and Galen Partners. PeriGen offers products and services including PeriWatch Surveillance, PeriWatch Vigilance, Vigilance Mobile, and LaborWatch. PeriGen operates in a competitive market with competitors including Curelink, SentiaCare, Jingu Health, Mediscale and GestInTime, among others.
- Headquarter Cranbury, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Perigen
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PeriGen
PeriGen offers a comprehensive portfolio of products and services, including PeriWatch Surveillance, PeriWatch Vigilance, Vigilance Mobile, and LaborWatch.
Provides real-time monitoring and early warnings for labor risks.
Offers standalone tools for maternal-fetal health tracking and alerts.
Enables remote access to perinatal data for on-the-go clinical decisions.
Analyzes labor data to reduce complications and improve patient safety.
Funding Insights of PeriGen
PeriGen has successfully raised a total of $11M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PeriGen
PeriGen has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Halma, Ambina Partners and Galen Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity and debt capital is provided to middle market companies.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US ventures are made by Trident Capital.
|
Locked | Locked | Locked |
Investor details for PeriGen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PeriGen
Investment portfolio details for PeriGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PeriGen
Detailed financials for PeriGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Perigen Comparisons
Peer comparison for PeriGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PeriGen
PeriGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curelink, SentiaCare, Jingu Health, Mediscale and GestInTime, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital telehealth and consultation platform for chronic care
|
|
| Locked | Locked | Locked |
Provider of an app for pregnant women
|
|
| Locked | Locked | Locked |
Offers AI-based diagnostic services for vaginal infections.
|
|
| Locked | Locked | Locked |
Helps doctors monitor the medical status of pregnant patients and provide web-based recommendations.
|
|
| Locked | Locked | Locked |
Offers a cloud-based platform for at-home prenatal care, supporting expectant parents with accessible health services.
|
Detailed competitors of PeriGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perigen
Complete news archive for PeriGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PeriGen
PeriGen was founded in 1995 and raised its 1st funding round 15 years after it was founded.
PeriGen is headquartered in Cranbury, United States. It is registered at Cranbury, New Jersey, United States.
PeriGen is a funded company, having raised a total of $11M across 3 funding rounds to date.
PeriGen operates as a company that specializes in risk reduction and clinical quality improvement in obstetrics. It provides PERIBIRTH, a clinical decision support system for obstetrics; PERICALM, an electronic fetal monitoring solution; and reporting and analytics solutions. The company also offers consulting services, such as perinatal safety and risk assessments, protocol and clinical workflow review and design, training and skills development; and ambulatory solutions for clinicians and physician practices. Its clients include multi-hospital systems, academic institutions, and small community-based hospitals. PeriGen was formerly known as EC Medical Intelligence.
PeriGen's top competitors include Curelink, SentiaCare and riskLD.
PeriGen offers PeriWatch Surveillance, PeriWatch Vigilance, Vigilance Mobile, and LaborWatch.
PeriGen has 5 investors. Key investors include Halma, Ambina Partners, Galen Partners, Trident Capital, and Salmon River Capital.